USD 13.02
(0.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 340.69 Million USD | 34.08% |
2022 | 254.1 Million USD | 8.34% |
2021 | 234.54 Million USD | 140.35% |
2020 | 97.58 Million USD | 30.89% |
2019 | 74.55 Million USD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 310.46 Million USD | -7.21% |
2024 Q1 | 334.59 Million USD | -1.79% |
2023 Q1 | 313.54 Million USD | 23.39% |
2023 FY | 340.69 Million USD | 34.08% |
2023 Q4 | 340.69 Million USD | 16.14% |
2023 Q3 | 293.35 Million USD | -2.49% |
2023 Q2 | 300.83 Million USD | -4.05% |
2022 Q3 | 256.96 Million USD | -3.05% |
2022 FY | 254.1 Million USD | 8.34% |
2022 Q2 | 265.04 Million USD | -1.37% |
2022 Q1 | 268.73 Million USD | 14.58% |
2022 Q4 | 254.1 Million USD | -1.11% |
2021 Q2 | 123.86 Million USD | 0.0% |
2021 FY | 234.54 Million USD | 140.35% |
2021 Q1 | - USD | -100.0% |
2021 Q4 | 234.54 Million USD | 92.96% |
2021 Q3 | 121.54 Million USD | -1.87% |
2020 FY | 97.58 Million USD | 30.89% |
2020 Q1 | - USD | 0.0% |
2020 Q4 | 97.58 Million USD | 0.0% |
2019 FY | 74.55 Million USD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Abbott Laboratories | 73.21 Billion USD | 99.535% |
Allurion Technologies Inc. | 71.71 Million USD | -375.093% |
Artivion, Inc. | 792.39 Million USD | 57.004% |
Avanos Medical, Inc. | 1.69 Billion USD | 79.869% |
Butterfly Network, Inc. | 304.27 Million USD | -11.971% |
Butterfly Network, Inc. | 304.27 Million USD | -11.971% |
Bio-Rad Laboratories, Inc. | 12.29 Billion USD | 97.23% |
Boston Scientific Corporation | 35.13 Billion USD | 99.03% |
CONMED Corporation | 2.3 Billion USD | 85.187% |
Edwards Lifesciences Corporation | 9.36 Billion USD | 96.361% |
Glaukos Corporation | 940.41 Million USD | 63.771% |
Globus Medical, Inc. | 5.08 Billion USD | 93.301% |
Inspire Medical Systems, Inc. | 676.81 Million USD | 49.661% |
Integer Holdings Corporation | 2.94 Billion USD | 88.422% |
Medtronic plc | 89.98 Billion USD | 99.621% |
Myomo, Inc. | 14.58 Million USD | -2236.505% |
Nevro Corp. | 635.71 Million USD | 46.407% |
Owlet, Inc. | 44.12 Million USD | -672.157% |
Penumbra, Inc. | 1.55 Billion USD | 78.108% |
Vicarious Surgical Inc. | 119.86 Million USD | -184.238% |
Smith & Nephew plc | 9.98 Billion USD | 96.589% |
Sonendo, Inc. | 78.16 Million USD | -335.899% |
STERIS plc | 11.06 Billion USD | 96.921% |
Stryker Corporation | 39.91 Billion USD | 99.146% |
Vapotherm, Inc. | 77.61 Million USD | -338.949% |
Zimmer Biomet Holdings, Inc. | 21.49 Billion USD | 98.415% |